Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
JP3 2551
European, News 13/12/2023

Secerna Receives Ongoing Recognition by International Rating Agency Leaders League

AI & Law (3)
Industry news, News 11/12/2023

High Court Breakthrough: Overturning UKIPO Decision Opens Doors for AI Patentability

Secerna Website Images 2023 (31)
European, Industry news, News 08/12/2023

Navigating the Future of European MedTech: Innovation Amidst Regulatory Hurdles

Secerna Website Images 2023 (5)
European, Industry news, News 05/12/2023

UK's £80 billion Horizon research programme association officially confirmed

Secerna Website Images 2023 (29)
Industry news, News 04/12/2023

Flooding and Intellectual Property: Protecting Both Tangible and Intangible Assets

Secerna Website Images 2023 (27)
European, News 28/11/2023

EPO Accelerates Opposition Proceedings for Infringement and Revocation

Secerna Website Images 2023 (23)
Industry news, News, Team news 23/11/2023

Secerna Awarded Internship Employer of the Year

Secerna Website Images 2023 (22)
European, Events 20/11/2023

Secerna to attend MedTech Rising in Galway

Secerna Website Images 2023 (20)
Industry news, News 08/11/2023

The Value of Designs in Your Intellectual Property Portfolio

11 12 13 14 15 16 17 18 19 20 21